{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:03:13Z","timestamp":1791932593624,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Bank"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10561-022-10062-0","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:03:06Z","timestamp":1671285786000},"page":"639-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Regenerative medicine improve neurodegenerative diseases"],"prefix":"10.1007","volume":"24","author":[{"given":"Seyedeh Sara","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Hosseinpour Sarmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Naderi Garahgheshlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Moghadamifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Lena","family":"Mohebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Brouki Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Amin","family":"Haramshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-8180","authenticated-orcid":false,"given":"Nooshin","family":"Ahmadirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"issue":"8","key":"10062_CR1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/molecules22081370","volume":"22","author":"BA Aderibigbe","year":"2017","unstructured":"Aderibigbe BA (2017) Metal-based nanoparticles for the treatment of infectious diseases. Molecules 22(8):1370","journal-title":"Molecules"},{"issue":"3","key":"10062_CR2","first-page":"1","volume":"2","author":"M Alam","year":"2021","unstructured":"Alam M, Abbas K (2021) An insight into neurodegenerative disorders, their therapeutic approaches and drugs available for tackling with neurodegeneration: a review. IAR J Med Case Rep 2(3):1","journal-title":"IAR J Med Case Rep"},{"issue":"1","key":"10062_CR3","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11033-018-4499-7","volume":"46","author":"M Alipour","year":"2019","unstructured":"Alipour M et al (2019) Stem cell therapy in Alzheimer\u2019s disease: possible benefits and limiting drawbacks. Mol Biol Rep 46(1):1425\u20131446","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10062_CR4","first-page":"826","volume":"140","author":"S Alves","year":"2017","unstructured":"Alves S et al (2017) Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer\u2019s disease mice. Brain 140(3):826\u2013842","journal-title":"Brain"},{"issue":"4","key":"10062_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12640-016-9599-3","volume":"29","author":"N Amini","year":"2016","unstructured":"Amini N et al (2016) Efficacy of human adipose tissue-derived stem cells on neonatal bilirubin encephalopathy in rats. Neurotox Res 29(4):514\u2013524","journal-title":"Neurotox Res"},{"issue":"2","key":"10062_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1574888X13666180720112322","volume":"14","author":"N Amini","year":"2019","unstructured":"Amini N et al (2019) Transplantation of adipose tissue-derived stem cells into brain through cerebrospinal fluid in rat models: protocol development and initial outcome data. Curr Stem Cell Res Ther 14(2):191\u2013195","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"10062_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/154916804323105053","volume":"7","author":"A Atala","year":"2004","unstructured":"Atala A (2004) Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res 7(1):15\u201331","journal-title":"Rejuvenation Res"},{"issue":"6990","key":"10062_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","volume":"429","author":"M Azzouz","year":"2004","unstructured":"Azzouz M et al (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429(6990):413\u2013417","journal-title":"Nature"},{"issue":"2","key":"10062_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1574888X13666180918093822","volume":"14","author":"A Babahajian","year":"2019","unstructured":"Babahajian A et al (2019) Neuroprotective effects of trolox, human chorionic gonadotropin, and carnosic acid on hippocampal neurodegeneration after ischemia-reperfusion injury. Curr Stem Cell Res Ther 14(2):177\u2013183","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"10062_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1566523217666170510153845","volume":"17","author":"P Bangde","year":"2017","unstructured":"Bangde P et al (2017) Potential gene therapy towards treating neurodegenerative disea ses employing polymeric nanosystems. Curr Gene Ther 17(2):170\u2013183","journal-title":"Curr Gene Ther"},{"issue":"9","key":"10062_CR11","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ymthe.2017.05.017","volume":"25","author":"MG Biferi","year":"2017","unstructured":"Biferi MG et al (2017) A new AAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model. Mol Ther 25(9):2038\u20132052","journal-title":"Mol Ther"},{"issue":"6","key":"10062_CR12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/75705","volume":"3","author":"A Bj\u00f6rklund","year":"2000","unstructured":"Bj\u00f6rklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Nat Neurosci 3(6):537\u2013544","journal-title":"Nat Neurosci"},{"issue":"5","key":"10062_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR et al (2000) El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"11","key":"10062_CR14","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1021\/acsami.7b01171","volume":"9","author":"T Chen","year":"2017","unstructured":"Chen T et al (2017) Small-sized mPEG\u2013PLGA nanoparticles of schisantherin a with sustained release for enhanced brain uptake and anti-parkinsonian activity. ACS Appl Mater Interfaces 9(11):9516\u20139527","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10062_CR15","doi-asserted-by":"crossref","first-page":"1703458","DOI":"10.1002\/adma.201703458","volume":"30","author":"W Chen","year":"2018","unstructured":"Chen W et al (2018) Black phosphorus nanosheets as a neuroprotective nanomedicine for neurodegenerative disorder therapy. Adv Mater 30(3):1703458","journal-title":"Adv Mater"},{"issue":"21","key":"10062_CR16","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1021\/acsami.6b03668","volume":"8","author":"SR Chowdhury","year":"2016","unstructured":"Chowdhury SR et al (2016) Modulation of amyloid aggregates into nontoxic coaggregates by hydroxyquinoline appended polyfluorene. ACS Appl Mater Interface 8(21):13309\u201313319","journal-title":"ACS Appl Mater Interface"},{"key":"10062_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468","journal-title":"Annu Rev Immunol"},{"key":"10062_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-319-40764-7_10","volume":"1","author":"F Cornejo","year":"2016","unstructured":"Cornejo F, von Bernhardi R (2016) Age-dependent changes in the activation and regulation of microglia. Gl Cell Health Disease CNS. 1:205","journal-title":"Gl Cell Health Disease CNS."},{"issue":"2","key":"10062_CR19","first-page":"109","volume":"4","author":"J Cummings","year":"2017","unstructured":"Cummings J, Fox N (2017) Defining disease modifying therapy for Alzheimer\u2019s disease. J Prev Alzheimers Dis 4(2):109\u2013115","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10062_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","volume":"3","author":"J Cummings","year":"2017","unstructured":"Cummings J et al (2017) Alzheimer\u2019s disease drug development pipeline: 2017. Alzheimer\u2019s Dement Trans Res Clin Interv 3(3):367\u2013384","journal-title":"Alzheimer's Dement Trans Res Clin Interv"},{"issue":"6","key":"10062_CR21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong X (2018) Current strategies for brain drug delivery. Theranostics 8(6):1481\u20131493","journal-title":"Theranostics"},{"issue":"3","key":"10062_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2012.08.008","volume":"65","author":"S El Andaloussi","year":"2013","unstructured":"El Andaloussi S et al (2013) Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 65(3):391\u2013397","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10062_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nbd.2009.07.022","volume":"36","author":"M Emborg","year":"2009","unstructured":"Emborg M et al (2009) Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis 36(2):303\u2013311","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10062_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-11-75","volume":"11","author":"AM Enciu","year":"2011","unstructured":"Enciu AM et al (2011) Neuroregeneration in neurodegenerative disorders. BMC Neurol 11(1):1\u20137","journal-title":"BMC Neurol"},{"issue":"175","key":"10062_CR25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1006\/exnr.2002.7949","volume":"2","author":"S Garbuzova-Davis","year":"2002","unstructured":"Garbuzova-Davis S et al (2002) Positive effect of transplantation of hNT neurons (NTera 2\/D1 Cell-Line) in a model of familial amyotrophic lateral sclerosis-volume 174, number 2 (2002) pages 169-180. Exp Neurol 2(175):451","journal-title":"Exp Neurol"},{"issue":"6","key":"10062_CR26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/brain\/122.6.1121","volume":"122","author":"P Hagell","year":"1999","unstructured":"Hagell P et al (1999) Sequential bilateral transplantation in Parkinson\u2019s disease: effects of the second graft. Brain 122(6):1121\u20131132","journal-title":"Brain"},{"issue":"5580","key":"10062_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"18","key":"10062_CR28","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1073\/pnas.0401103101","volume":"101","author":"JM Harper","year":"2004","unstructured":"Harper JM et al (2004) Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci 101(18):7123\u20137128","journal-title":"Proc Natl Acad Sci"},{"key":"10062_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2013.04.011","volume":"58","author":"CD Herzog","year":"2013","unstructured":"Herzog CD et al (2013) Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120). Neurobiol Dis 58:38\u201348","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10062_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-4422(15)00332-4","volume":"15","author":"JG Hunsberger","year":"2016","unstructured":"Hunsberger JG et al (2016) Accelerating stem cell trials for Alzheimer\u2019s disease. Lancet Neurol 15(2):219\u2013230","journal-title":"Lancet Neurol"},{"issue":"10","key":"10062_CR31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/gt.2009.80","volume":"16","author":"D Hwang","year":"2009","unstructured":"Hwang D et al (2009) Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther 16(10):1234\u20131244","journal-title":"Gene Ther"},{"issue":"4","key":"10062_CR32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic J, Aguilar LG (2008) Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatr Dis Treat 4(4):743\u2013757","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"10062_CR33","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1523\/JNEUROSCI.23-12-05131.2003","volume":"23","author":"DA Kerr","year":"2003","unstructured":"Kerr DA et al (2003) Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 23(12):5131\u20135140","journal-title":"J Neurosci"},{"issue":"9769","key":"10062_CR34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC et al (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942\u2013955","journal-title":"Lancet"},{"issue":"10","key":"10062_CR35","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jnr.22054","volume":"87","author":"SU Kim","year":"2009","unstructured":"Kim SU, De Vellis J (2009) Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87(10):2183\u20132200","journal-title":"J Neurosci Res"},{"issue":"11","key":"10062_CR36","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/mt.2015.142","volume":"23","author":"T Kiyota","year":"2015","unstructured":"Kiyota T et al (2015) AAV2\/1 CD74 gene transfer reduces \u03b2-amyloidosis and improves learning and memory in a mouse model of Alzheimer\u2019s disease. Mol Ther 23(11):1712\u20131721","journal-title":"Mol Ther"},{"issue":"1","key":"10062_CR37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 9(1):1305","journal-title":"Nat Commun"},{"issue":"39","key":"10062_CR38","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1523\/JNEUROSCI.0084-17.2017","volume":"37","author":"JA Korecka","year":"2017","unstructured":"Korecka JA et al (2017) Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson\u2019s disease. J Neurosci 37(39):9361\u20139379","journal-title":"J Neurosci"},{"key":"10062_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","volume":"17","author":"MA Kotterman","year":"2015","unstructured":"Kotterman MA, Chalberg TW, Schaffer DV (2015) Viral vectors for gene therapy: translational and clinical outlook. Annu Rev Biomed Eng 17:63\u201389","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"10062_CR40","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","volume":"2","author":"HJ Lee","year":"2007","unstructured":"Lee HJ et al (2007) Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2(1):e156","journal-title":"PLoS ONE"},{"key":"10062_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.parkreldis.2019.05.032","volume":"65","author":"PA LeWitt","year":"2019","unstructured":"LeWitt PA, Giladi N, Navon N (2019) Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill\u00ae) in Parkinson\u2019s disease. Parkinsonism Relat Disord 65:131\u2013138","journal-title":"Parkinsonism Relat Disord"},{"key":"10062_CR42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuroscience.2017.10.001","volume":"365","author":"D Li","year":"2017","unstructured":"Li D et al (2017) Slow intrathecal injection of rAAVrh10 enhances its transduction of spinal cord and therapeutic efficacy in a mutant SOD1 model of ALS. Neuroscience 365:192\u2013205","journal-title":"Neuroscience"},{"issue":"1","key":"10062_CR43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders\u2014time for clinical translation? J Clin Investig 120(1):29\u201340","journal-title":"J Clin Investig"},{"issue":"21","key":"10062_CR44","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2217\/nnm-2017-0228","volume":"12","author":"V Maney","year":"2017","unstructured":"Maney V, Singh M (2017) An in vitro assessment of novel chitosan\/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin. Nanomedicine 12(21):2625\u20132640","journal-title":"Nanomedicine"},{"issue":"25","key":"10062_CR45","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJM199906243402507","volume":"340","author":"JB Martin","year":"1999","unstructured":"Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med 340(25):1970\u20131980","journal-title":"N Engl J Med"},{"issue":"4","key":"10062_CR46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jps.24322","volume":"104","author":"Z Mazibuko","year":"2015","unstructured":"Mazibuko Z et al (2015) A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci 104(4):1213\u20131229","journal-title":"J Pharm Sci"},{"issue":"36","key":"10062_CR47","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1523\/JNEUROSCI.1972-04.2004","volume":"24","author":"GB Miles","year":"2004","unstructured":"Miles GB et al (2004) Functional properties of motoneurons derived from mouse embryonic stem cells. J Neurosci 24(36):7848\u20137858","journal-title":"J Neurosci"},{"issue":"3","key":"10062_CR48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5692\/clinicalneurol.cn-001235","volume":"59","author":"A Morizane","year":"2019","unstructured":"Morizane A (2019) Cell therapy for Parkinson\u2019s disease with induced pluripotent stem cells. Rinsho Shinkeigaku Clin Neurol 59(3):119\u2013124","journal-title":"Rinsho Shinkeigaku Clin Neurol"},{"key":"10062_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fnmol.2014.00076","volume":"7","author":"G Murlidharan","year":"2014","unstructured":"Murlidharan G, Samulski RJ, Asokan A (2014) Biology of adeno-associated viral vectors in the central nervous system. Front Mol Neurosci 7:76","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"10062_CR50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.molmed.2015.06.001","volume":"21","author":"DM O\u2019Connor","year":"2015","unstructured":"O\u2019Connor DM, Boulis NM (2015) Gene therapy for neurodegenerative diseases. Trends Mol Med 21(8):504\u2013512","journal-title":"Trends Mol Med"},{"issue":"1","key":"10062_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/1673-5374.224362","volume":"13","author":"IG Onyango","year":"2018","unstructured":"Onyango IG (2018) Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer\u2019s disease. Neural Regen Res 13(1):19","journal-title":"Neural Regen Res"},{"issue":"1","key":"10062_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/187221412799015245","volume":"6","author":"S Ortolano","year":"2012","unstructured":"Ortolano S, Spuch C, Navarro C (2012) Present and future of adeno associated virus based gene therapy approaches. Recent Pat Endocr Metab Immune Drug Discove 6(1):47\u201366","journal-title":"Recent Pat Endocr Metab Immune Drug Discove"},{"issue":"5","key":"10062_CR53","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1021\/nn506408v","volume":"9","author":"R Pahuja","year":"2015","unstructured":"Pahuja R et al (2015) Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats. ACS Nano 9(5):4850\u20134871","journal-title":"ACS Nano"},{"issue":"11","key":"10062_CR54","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1089\/hum.2017.160","volume":"28","author":"F Piguet","year":"2017","unstructured":"Piguet F, Alves S, Cartier N (2017) Clinical gene therapy for neurodegenerative diseases: past, present, and future. Hum Gene Ther 28(11):988\u20131003","journal-title":"Hum Gene Ther"},{"issue":"7588","key":"10062_CR55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay S et al (2016) An essential receptor for adeno-associated virus infection. Nature 530(7588):108\u2013112","journal-title":"Nature"},{"issue":"1","key":"10062_CR56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3727\/000000007783464443","volume":"16","author":"F Pisati","year":"2007","unstructured":"Pisati F et al (2007) Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant 16(1):41\u201355","journal-title":"Cell Transplant"},{"issue":"6","key":"10062_CR57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4103\/1673-5374.250570","volume":"14","author":"Y Qu","year":"2019","unstructured":"Qu Y et al (2019) Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases. Neural Regen Res 14(6):931","journal-title":"Neural Regen Res"},{"issue":"5","key":"10062_CR58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","volume":"10","author":"MS Rafii","year":"2014","unstructured":"Rafii MS et al (2014) A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease. Alzheimers Dement 10(5):571\u2013581","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10062_CR59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12035-018-1068-y","volume":"56","author":"SP Raikwar","year":"2019","unstructured":"Raikwar SP et al (2019) Targeted gene editing of glia maturation factor in microglia: a novel Alzheimer\u2019s disease therapeutic target. Mol Neurobiol 56(1):378\u2013393","journal-title":"Mol Neurobiol"},{"key":"10062_CR60","doi-asserted-by":"crossref","unstructured":"MS Rao, A Khanna, S Shin, (2008) Stem cells for the treatment of neurological disorders. CNS Neurol Disord-Drug Targ (Former Curr Drug Targ-CNS Neurol Disord), 7(1): p. 98-109","DOI":"10.2174\/187152708783885183"},{"issue":"1","key":"10062_CR61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/mt.2011.177","volume":"20","author":"K Rapti","year":"2012","unstructured":"Rapti K et al (2012) Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. Mol Ther 20(1):73\u201383","journal-title":"Mol Ther"},{"issue":"29","key":"10062_CR62","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.1073\/pnas.0704091104","volume":"104","author":"DE Redmond","year":"2007","unstructured":"Redmond DE et al (2007) Behavioral improvement in a primate Parkinson\u2019s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci 104(29):12175\u201312180","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10062_CR63","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","volume":"82","author":"M Ristow","year":"2004","unstructured":"Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82(8):510\u2013529","journal-title":"J Mol Med"},{"issue":"22","key":"10062_CR64","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun D et al (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365(22):2067\u20132077","journal-title":"N Engl J Med"},{"issue":"2","key":"10062_CR65","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","volume":"152","author":"JK Sahni","year":"2011","unstructured":"Sahni JK et al (2011) Neurotherapeutic applications of nanoparticles in Alzheimer\u2019s disease. J Control Release 152(2):208\u2013231","journal-title":"J Control Release"},{"issue":"23","key":"10062_CR66","first-page":"1822","volume":"7","author":"R Sakthiswary","year":"2012","unstructured":"Sakthiswary R, Raymond AA (2012) Stem cell therapy in neurodegenerative diseases: from principles to practice. Neural Regen Res 7(23):1822","journal-title":"Neural Regen Res"},{"issue":"3","key":"10062_CR67","first-page":"315","volume":"12","author":"D Sanooghi","year":"2021","unstructured":"Sanooghi D et al (2021) Differentiation of mesenchymal stem cells derived from human adipose tissue into cholinergic-like cells: an in vitro study. Basic Clin Neurosci 12(3):315","journal-title":"Basic Clin Neurosci"},{"issue":"1","key":"10062_CR68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/02648725.2018.1523521","volume":"35","author":"AO Sasmita","year":"2019","unstructured":"Sasmita AO (2019) Current viral-mediated gene transfer research for treatment of Alzheimer\u2019s disease. Biotechnol Genet Eng Rev 35(1):26\u201345","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"3","key":"10062_CR69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157015908785777210","volume":"6","author":"SM Stamatovic","year":"2008","unstructured":"Stamatovic SM, Keep RF, Andjelkovic AV (2008) Brain endothelial cell-cell junctions: how to \u201copen\u201d the blood brain barrier. Curr Neuropharmacol 6(3):179\u2013192","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10062_CR70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI21137","volume":"115","author":"Y Takagi","year":"2005","unstructured":"Takagi Y et al (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Investig 115(1):102\u2013109","journal-title":"J Clin Investig"},{"key":"10062_CR71","first-page":"1745","volume":"11","author":"BC-K Tong","year":"1865","unstructured":"Tong BC-K et al (1865) (2018) Calcium signaling in Alzheimer\u2019s disease & therapies. Biochimica Et Biophysica Acta (BBA)-Mol Cell Res. 11:1745","journal-title":"Biochimica Et Biophysica Acta (BBA)-Mol Cell Res."},{"issue":"15","key":"10062_CR72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm-2021-0044","volume":"16","author":"J Venkatas","year":"2021","unstructured":"Venkatas J, Singh M (2021) Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer. Nanomedicine 16(15):1311\u20131328","journal-title":"Nanomedicine"},{"issue":"10","key":"10062_CR73","first-page":"1","volume":"6","author":"M-M Wang","year":"2018","unstructured":"Wang M-M et al (2018) Innate immune activation in Alzheimer\u2019s disease. Ann Trans Med 6(10):1","journal-title":"Ann Trans Med"},{"issue":"4","key":"10062_CR74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<511::AID-JNR10>3.0.CO;2-I","volume":"60","author":"K Watabe","year":"2000","unstructured":"Watabe K et al (2000) Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 60(4):511\u2013519","journal-title":"J Neurosci Res"},{"issue":"7","key":"10062_CR75","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","volume":"82","author":"L Xu","year":"2006","unstructured":"Xu L et al (2006) Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82(7):865\u2013875","journal-title":"Transplantation"},{"issue":"13","key":"10062_CR76","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1021\/jp501114h","volume":"118","author":"JA Yang","year":"2014","unstructured":"Yang JA et al (2014) \u03b1-Synuclein\u2019s adsorption, conformation, and orientation on cationic gold nanoparticle surfaces seeds global conformation change. J Phys Chem B 118(13):3559\u20133571","journal-title":"J Phys Chem B"},{"key":"10062_CR77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fchem.2020.00376","volume":"8","author":"SB Yaqoob","year":"2020","unstructured":"Yaqoob SB et al (2020) Gold, silver, and palladium nanoparticles: a chemical tool for biomedical applications. Front Chem 8:376","journal-title":"Front Chem"},{"issue":"48","key":"10062_CR78","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","volume":"26","author":"T Yasuhara","year":"2006","unstructured":"Yasuhara T et al (2006) Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson\u2019s disease. J Neurosci 26(48):12497\u201312511","journal-title":"J Neurosci"},{"issue":"1","key":"10062_CR79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/1673-5374.125332","volume":"9","author":"L Yi","year":"2014","unstructured":"Yi L et al (2014) A non-invasive, rapid method to genotype late-onset Alzheimer\u2019s disease-related apolipoprotein E gene polymorphisms. Neural Regen Res 9(1):69","journal-title":"Neural Regen Res"},{"issue":"8","key":"10062_CR80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin H et al (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541\u2013555","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10062_CR81","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.7150\/thno.23734","volume":"8","author":"N Zhang","year":"2018","unstructured":"Zhang N et al (2018) Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson\u2019s disease therapy. Theranostics 8(8):2264","journal-title":"Theranostics"},{"key":"10062_CR82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao L et al (2016) Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol Aging 44:159\u2013172","journal-title":"Neurobiol Aging"},{"key":"10062_CR90","doi-asserted-by":"crossref","unstructured":"Kabanov A, Gendelman HE (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.\" Progress in Polymer Science 32(8\u20139):1054\u20131082","DOI":"10.1016\/j.progpolymsci.2007.05.014"},{"key":"10062_CR91","doi-asserted-by":"crossref","unstructured":"Lunn JS, Sakowski SA, Hur J, Feldman EL (2011) Stem cell technology for neurodegenerative diseases. Annu Neurol 70(3):353\u2013361","DOI":"10.1002\/ana.22487"}],"container-title":["Cell and Tissue Banking"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-022-10062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10561-022-10062-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-022-10062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:13:13Z","timestamp":1693390393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10561-022-10062-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10062"],"URL":"https:\/\/doi.org\/10.1007\/s10561-022-10062-0","relation":{},"ISSN":["1389-9333","1573-6814"],"issn-type":[{"value":"1389-9333","type":"print"},{"value":"1573-6814","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"30 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}